Author

K. S. Rathi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:differential expression· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

D. Martinez· 3 shared J. L. Rokita· 3 shared J. M. Maris· 3 shared D. Chen· 2 shared J. Pogoriler· 2 shared K. R. Bosse· 2 shared P. Raman· 2 shared R. W. Schnepp· 2 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. Martinez

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

A. K. Weiner, A. B. Radaoui, M. Tsang, D. Martinez, S. Sidoli, K. L. Conkrite, A. Delaidelli, A. Modi, J. L. Rokita, K. Patel, M. V. Lane, B. Zhang, C. Zhong, B. Ennis, D. P. Miller, , S. J. Diskin

This study identifies DLK1 as a potential immunotherapeutic target in neuroblastoma through integrative proteomic, transcriptomic, and epigenomic analysis.

bioRxiv · Dec 6, 2023 · PreprintCancer Biology

Epigenetic regulator BMI1 promotes fusion-positive rhabdomyosarcoma proliferation and constitutes a novel therapeutic target

C. E. Shields, S. Potlapalli, S. M. Cuya-Smith, S. K. Chappell, D. Chen, D. Martinez, J. Pogoriler, K. S. Rathi, S. A. Patel, J. M. Maris, R. W. Schnepp

This study shows BMI1 promotes FP-RMS proliferation and its inhibition reduces tumor growth and activates the Hippo pathway.

bioRxiv · Apr 18, 2020Cancer Biology

Single-cell transcriptomic profile reveals macrophage heterogeneity in medulloblastoma and their treatment-dependent recruitment

M. T. Dang, M. Gonzalez, K. S. Gaonkar, K. S. Rathi, P. Young, S. Arif, L. Zhai, M. Alam, S. Devalaraja, T. Tsun, I. Folkert, P. Raman, J. L. Rokita, D. Martinez, J. Taroni, , M. Haldar

The paper uses single-cell and bulk RNA sequencing to study macrophage heterogeneity in medulloblastoma and shows differential recruitment with targeted vs. radiation therapy.

bioRxiv · Feb 12, 2020 · PreprintCancer Biology

LIN28B-PDZ Binding Kinase Signaling Promotes Neuroblastoma Metastasis

D. Chen, J. Cox, J. Annam, M. Weingart, G. Essien, K. S. Rathi, J. L. Rokita, P. Khurana, S. M. Cuya, K. R. Bosse, A. Pilgrim, D. Li, J. M. Maris, R. W. Schnepp

This study identifies LIN28B's role in promoting neuroblastoma metastasis through the regulation of PBK, a kinase that enhances self-renewal and migration.

bioRxiv · Aug 21, 2019Cancer Biology